MedTrace Logo

Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout

NCT04953533 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-07-08

No results posted yet for this study

Summary

To evaluate differences in specific SNPs and intestinal microflora between patients with gout and hyperuricemia and healthy controls.

Conditions

  • Gout
  • Hyperuricemia
  • Gut Microbiota
  • Uric Acid
  • Genetic Loci
  • Single Nucleotide Polymorphism
  • Feces

Interventions

OTHER

no intervention

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Xiaoyong Liu, PHD · Second Affiliated Hospital of Zhejiang University School of Medicine

  • Lei Liu, PHD · Second Affiliated Hospital of Zhejiang University School of Medicine

  • Peiyu Zhang, MFA · Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang university,

  • Mo Chen, PHD · Second Affiliated Hospital of Zhejiang University School of Medicine

  • Jundi Wang, bachelor · Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang university,

  • Shunjie Hu, bachelor · Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang university,

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-06
Primary Completion
2023-01-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953533 on ClinicalTrials.gov